ZA907737B - Stable immunogen composition for oral administration - Google Patents
Stable immunogen composition for oral administrationInfo
- Publication number
- ZA907737B ZA907737B ZA907737A ZA907737A ZA907737B ZA 907737 B ZA907737 B ZA 907737B ZA 907737 A ZA907737 A ZA 907737A ZA 907737 A ZA907737 A ZA 907737A ZA 907737 B ZA907737 B ZA 907737B
- Authority
- ZA
- South Africa
- Prior art keywords
- oral administration
- immunogen composition
- stable
- stable immunogen
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25647289 | 1989-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA907737B true ZA907737B (en) | 1991-07-31 |
Family
ID=17293111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA907737A ZA907737B (en) | 1989-09-29 | 1990-09-27 | Stable immunogen composition for oral administration |
Country Status (10)
Country | Link |
---|---|
US (1) | US5176909A (xx) |
EP (1) | EP0420785B1 (xx) |
JP (1) | JPH03173829A (xx) |
CN (1) | CN1032348C (xx) |
AT (1) | ATE115860T1 (xx) |
AU (1) | AU634823B2 (xx) |
CA (1) | CA2026508A1 (xx) |
DE (1) | DE69015305T2 (xx) |
RU (2) | RU1836081C (xx) |
ZA (1) | ZA907737B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5334394A (en) * | 1990-06-22 | 1994-08-02 | The Regents Of The University Of California | Human immunodeficiency virus decoy |
US5178882A (en) * | 1990-06-22 | 1993-01-12 | The Regents Of The University Of California | Viral decoy vaccine |
CA2083553A1 (en) * | 1991-11-25 | 1993-05-26 | Kuniharu Seki | Immunogen composition |
AU7682896A (en) * | 1995-10-13 | 1997-04-30 | Zynaxis, Inc. | Solid, orally administrable viral vaccines and methods of preparation |
EP0867188A1 (en) * | 1996-08-20 | 1998-09-30 | Freund Industrial Co., Ltd. | Microspheres containing immunogens, process for producing the same, and method for immunizing animals with the use of the same |
US5741680A (en) * | 1996-09-03 | 1998-04-21 | Cera Products, Inc. | Buffer composition base and method of formulation for oral vaccine delivery |
AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
US20040057969A1 (en) * | 2002-09-20 | 2004-03-25 | Smith Mark L | Compositions containing stabilized hepatitis antigen and methods of their use |
BR0315767A (pt) * | 2002-11-01 | 2005-09-06 | Glaxosmithkline Biolog Sa | Composição imunogência, método para fabricar uma vacina, kit, vacina, recipiente com uma superfìcie interna repelente à água, e, método para preservar uma composição que compreende ipv e um agente estabilizador |
MXPA05013234A (es) * | 2003-06-10 | 2006-03-09 | Univ Saskatchewan | Proteinas de capside de adenovirus quimericas. |
JP2007060963A (ja) * | 2005-08-30 | 2007-03-15 | Eiyo Byorigaku Kenkyusho:Kk | 動物に病原体感染症を発症させるための動物用カプセル製剤およびそれを用いて動物に病原体感染症を発症させる方法 |
CN101896170A (zh) * | 2007-11-13 | 2010-11-24 | 赫尔克里士公司 | 用于营养品和药物剂型的水分散性肠溶衣配制物 |
RU2497541C1 (ru) * | 2012-07-20 | 2013-11-10 | федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почётного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Фармацевтическая композиция на основе лигандов паттерн-распознающих рецепторов, способ ее использования в качестве иммуностимулятора для лечения инфекций, вызванных бактериальными и вирусными патогенами, способ ее использования в качестве адъюванта в составе вакцин |
JP2016164149A (ja) * | 2015-02-27 | 2016-09-08 | 尾木 大 | コーティング剤組成物 |
CN114478074B (zh) * | 2022-01-12 | 2023-04-28 | 中北大学 | 羟基磷灰石嫁接钴包覆陶瓷复合粉末及其制备和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE621398A (xx) * | 1900-01-01 | |||
FR1497584A (fr) * | 1966-08-11 | 1967-10-13 | Roussel Uclaf | Procédé de fabrication de microcapsules |
JPS5537971A (en) * | 1978-09-11 | 1980-03-17 | Agency Of Ind Science & Technol | Fuel-injection-timing detector of diesel engine |
FR2464093A1 (fr) * | 1979-08-30 | 1981-03-06 | Roussel Uclaf | Procede de preparation de suspensions ou de poudres stables de microcapsules stables et d'une porosite variable et les produits ainsi obtenus |
SE441009B (sv) * | 1982-03-08 | 1985-09-02 | Kjell Nilsson | Sett att immobilisera levande biomaterial i perlformiga polymerer |
GB8326633D0 (en) * | 1983-08-04 | 1983-11-09 | Unilever Plc | Compositions |
EP0142193A1 (en) * | 1983-10-22 | 1985-05-22 | Akzo N.V. | Preparation of immunogens consisting of antigens and/or antigenic determinants bound to glycoside-containing carriers |
JPS62502262A (ja) * | 1985-03-27 | 1987-09-03 | ブロンコスタット・プロプライアタリー・リミテツド | アジユバントを含有しないワクチン |
JPH062665B2 (ja) * | 1987-10-06 | 1994-01-12 | 新田ゼラチン株式会社 | ゼラチン組成物 |
-
1990
- 1990-09-27 ZA ZA907737A patent/ZA907737B/xx unknown
- 1990-09-28 AU AU63607/90A patent/AU634823B2/en not_active Ceased
- 1990-09-28 AT AT90610064T patent/ATE115860T1/de not_active IP Right Cessation
- 1990-09-28 US US07/590,230 patent/US5176909A/en not_active Expired - Fee Related
- 1990-09-28 JP JP2262750A patent/JPH03173829A/ja active Pending
- 1990-09-28 EP EP90610064A patent/EP0420785B1/en not_active Expired - Lifetime
- 1990-09-28 CA CA002026508A patent/CA2026508A1/en not_active Abandoned
- 1990-09-28 DE DE69015305T patent/DE69015305T2/de not_active Expired - Fee Related
- 1990-09-28 RU SU904831416A patent/RU1836081C/ru active
- 1990-09-29 CN CN90109121A patent/CN1032348C/zh not_active Expired - Fee Related
-
1992
- 1992-06-15 RU SU925052185A patent/RU2069567C1/ru active
Also Published As
Publication number | Publication date |
---|---|
RU1836081C (ru) | 1993-08-23 |
AU634823B2 (en) | 1993-03-04 |
EP0420785A2 (en) | 1991-04-03 |
RU2069567C1 (ru) | 1996-11-27 |
DE69015305D1 (de) | 1995-02-02 |
ATE115860T1 (de) | 1995-01-15 |
JPH03173829A (ja) | 1991-07-29 |
US5176909A (en) | 1993-01-05 |
AU6360790A (en) | 1991-04-11 |
CN1050987A (zh) | 1991-05-01 |
CN1032348C (zh) | 1996-07-24 |
EP0420785B1 (en) | 1994-12-21 |
CA2026508A1 (en) | 1991-03-30 |
DE69015305T2 (de) | 1995-05-18 |
EP0420785A3 (en) | 1991-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA907737B (en) | Stable immunogen composition for oral administration | |
IE64786B1 (en) | Method and formulation for orally administering bioactive agents to and through the peyer's patch | |
PT839525E (pt) | Preparacao de libertacao prolongada | |
FR2604090B1 (fr) | Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee | |
EP0397652A4 (en) | Water insoluble derivatives of hyaluronic acid | |
ZA909685B (en) | Pharmaceutical compositions | |
DE3766200D1 (de) | L-dopa enthaltendes arzneimittel. | |
NO160412C (no) | Inert matrise basert paa polykaprolakton for oral administrasjon av et legemiddel, og fremgangsmaate for fremstillingav den galeniske form omfattende denne matrise. | |
ATE100095T1 (de) | 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
IL88020A0 (en) | Oral formulation of buspirone and salts thereof | |
NZ229023A (en) | 1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation | |
GR3000305T3 (en) | Improved antiinflammatory compositions and methods | |
IL85144A0 (en) | Controlled and delayed release oral pharmaceutical compositions and their preparation | |
IL98117A0 (en) | 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines,their preparation and pharmaceutical compositions containing them | |
IL81197A0 (en) | Methionine-substituted 1,4-dihydropyridines,their preparation and medicaments containing them | |
IL87104A0 (en) | Pest-combating compositions comprising derivatives of 2,3-diaminomaleonitrile,certain such new derivatives and their preparation | |
CS237489A1 (en) | Copolymers of 2,3-epoxypropyl-a/2,3-epithiopropyl/-2-propenolates and method of their preparation | |
CS592187A1 (en) | Veterinary preparation for hoofed game's immobilization and method of its production |